Provided by Tiger Fintech (Singapore) Pte. Ltd.

Rezolute, Inc.

5.50
+0.13002.42%
Volume:414.36K
Turnover:2.33M
Market Cap:477.48M
PE:-4.93
High:5.84
Open:5.43
Low:5.43
Close:5.37
Loading ...

Rezolute Gets US FDA Breakthrough Therapy Designation for Hypoglycemia Treatment

MT Newswires Live
·
05 May

Analysts Are Bullish on These Healthcare Stocks: Capricor Therapeutics (CAPR), Rezolute (RZLT)

TIPRANKS
·
05 May

Rezolute Receives Breakthrough Therapy Designation from FDA for Ersodetug in the Treatment of Hypoglycemia Due to Tumor Hyperinsulinism

GlobeNewswire
·
05 May

Rezolute to Participate in Upcoming Investor Conferences

GlobeNewswire
·
01 May

Rezolute Price Target Maintained With a $14.00/Share by HC Wainwright & Co.

Dow Jones
·
29 Apr

H.C. Wainwright keeps Buy on Rezolute after no changes to sunRIZE sample size

TIPRANKS
·
28 Apr

Rezolute, Inc. Announces Closing of Underwritten Offering

GlobeNewswire
·
26 Apr

Maxim Group Sticks to Its Buy Rating for Rezolute (RZLT)

TIPRANKS
·
25 Apr

Rezolute Shares Rise After Recommendation to Continue Phase 3 Ersodetug Study

Dow Jones
·
23 Apr

Rezolute Prices $90 Million Securities Offering

MT Newswires Live
·
23 Apr

Rezolute Gets Independent DMC's Positive Recommendation to Continue Ersodetug Study -- Shares Surge Pre-Bell

MT Newswires Live
·
23 Apr

BRIEF-Rezolute Announces Pricing Of Offering Of $90 Million Of Common Stock And Pre-Funded Warrants

Reuters
·
23 Apr

Rezolute Announces Pricing of Offering of $90 Million of Common Stock and Pre-Funded Warrants

GlobeNewswire
·
23 Apr

Rezolute Announces Positive Recommendation After Independent Interim Analysis of Phase 3 sunRIZE Study of Ersodetug in Congenital Hyperinsulinism (“HI”)

GlobeNewswire
·
23 Apr

Is Rezolute (NASDAQ:RZLT) In A Good Position To Deliver On Growth Plans?

Simply Wall St.
·
22 Apr

Press Release: Rezolute Announces Appointment of Rare Disease Commercial Leader Erik Harris to its Board of Directors

Dow Jones
·
26 Mar

Rezolute Price Target Maintained With a $14.00/Share by HC Wainwright & Co.

Dow Jones
·
14 Feb

Analysts Offer Insights on Healthcare Companies: Rezolute (RZLT) and Crispr Therapeutics AG (CRSP)

TIPRANKS
·
13 Feb

Rezolute Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
13 Feb

Rezolute Q2 EPS $(0.22) Beats $(0.25) Estimate

Benzinga
·
13 Feb